Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UPF3A pseudogene 1 is a non-coding, inactive genomic locus related to the functional UPF3A gene. It does NOT produce a functional protein, is NOT considered a drug target, and should NOT be used for structured drug discovery/disease annotation. In contrast, UPF3A is a key regulator in the nonsense-mediated mRNA decay pathway, where it acts as a NMD repressor, important for developmental regulation (especially in germ cells) by controlling the stability of transcripts with premature stop codons, thus influencing gene expression and cell fate decisions. UPF3A itself is not a common drug target but is relevant in the context of basic research in RNA processing, gene regulation, and certain developmental or tumorigenic diseases.
None established for pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UPF3A pseudogene 1 (UPF3AP1).